Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity
暂无分享,去创建一个
Pooja Manchandani | Vincent H. Tam | Kimberly R. Ledesma | L. Truong | V. Tam | Jian Zhou | Jessica T. Babic | Luan D. Truong | Jian Zhou | Pooja Manchandani | K. R. Ledesma
[1] E. Christensen,et al. Role of megalin and cubilin in renal physiology and pathophysiology. , 2007, Reviews of physiology, biochemistry and pharmacology.
[2] A. Saito,et al. The Endocytic Receptor Megalin and its Associated Proteins in Proximal Tubule Epithelial Cells , 2014, Membranes.
[3] V. Tam,et al. Risk factors for nephrotoxicity onset associated with polymyxin B therapy. , 2015, The Journal of antimicrobial chemotherapy.
[4] G. Forrest,et al. Polymyxin antibiotics for gram-negative infections. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[5] J. Rastad,et al. Tissue Distribution of Human gp330/Megalin, a Putative Ca2+-sensing Protein , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] S. Moestrup,et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. , 1995, The Journal of clinical investigation.
[7] G. Turett,et al. Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria , 2003, Antimicrobial Agents and Chemotherapy.
[8] M. Rowling,et al. Vitamin D Transport Proteins Megalin and Disabled-2 Are Expressed in Prostate and Colon Epithelial Cells and Are Induced and Activated by All-Trans-Retinoic Acid , 2013, Nutrition and cancer.
[9] L. Truong,et al. Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model , 2015, Antimicrobial Agents and Chemotherapy.
[10] F. Luft,et al. Megalin Deficiency Offers Protection from Renal Aminoglycoside Accumulation* , 2002, The Journal of Biological Chemistry.
[11] A. Bonvin,et al. Gentamicin Binds to the Megalin Receptor as a Competitive Inhibitor Using the Common Ligand Binding Motif of Complement Type Repeats , 2012, The Journal of Biological Chemistry.
[12] Roger L. Nation,et al. Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells , 2013, Antimicrobial Agents and Chemotherapy.
[13] V. Tam,et al. Comparative Pharmacokinetic Profiling of Different Polymyxin B Components , 2016, Antimicrobial Agents and Chemotherapy.
[14] Douglas Ferguson,et al. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[15] H. Yamaguchi,et al. Megalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin , 2013, Antimicrobial Agents and Chemotherapy.
[16] S. Moestrup,et al. Renal tubule gp330 is a calcium binding receptor for endocytic uptake of protein. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[17] J. Li,et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] S. Moestrup,et al. Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. , 2002, Journal of the American Society of Nephrology : JASN.
[19] V. Tam,et al. In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy , 2014, Antimicrobial Agents and Chemotherapy.
[20] M. Marzolo,et al. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. , 2011, Biological research.
[21] E. Burdmann,et al. Prevalence and Risk Factors for Acute Kidney Injury Associated with Parenteral Polymyxin B Use , 2009, The Annals of pharmacotherapy.
[22] Ming Hu,et al. Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design , 2012, Antimicrobial Agents and Chemotherapy.
[23] V. Tam,et al. Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model , 2012, Antimicrobial Agents and Chemotherapy.
[24] K. Sekhri,et al. To study the clinical efficacy and nephrotoxicity along with the risk factors for acute kidney injury associated with parenteral polymyxin B , 2013, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.